China Sky One Starts Shift From OTC To Prescription Market
This article was originally published in PharmAsia News
Executive Summary
SHANGHAI - China Sky One Medical entered 11 new drugs enter into clinical trials, seven of which are injectable drugs, the company announced June 10, which could lead to the company's first foray into the injectable drug market in China